Examples of using Combivir in English and their translations into Danish
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Official/political
-
Computer
What is the risk associated with Combivir?
warnings relevant to the combination Combivir.
Combivir is therefore contra- indicated in these patients see section 4.4.
Combivir has been shown to significantly reduce the risk of disease progression.
Combivir was effective at reducing viral loads
zidovudine as separate medicines instead of Combivir.
A bioequivalence study compared Combivir with lamivudine 150 mg
These may affect the action of Combivir, or Combivir may affect their action.
Patients receiving Combivir or any other antiretroviral therapy may continue to develop opportunistic infections and other complications of HIV infection.
The European Commission granted a marketing authorisation valid throughout the EU for Combivir to Glaxo Group Ltd on 18 March 1998.
Combivir is used in antiretroviral combination therapy for the treatment of HIV infection in patients weighing more than 14 kg.
Combivir belongs to a group of antiviral medicines,
As Combivir contains lamivudine
The class of medicines to which Combivir belongs(NRTIs) can cause a condition called lactic acidosis,
with higher doses of zidovudine than the dose in Combivir.
Combivir was shown to be bioequivalent to lamivudine 150 mg and zidovudine 300 mg given as separate tablets, when administered to fasting subjects.
patients taking Combivir and those taking the two active substances separately had similar falls in viral load.
Pregnant women considering using Combivir during pregnancy should be made aware of the findings from animal carcinogenicity
While you are being treated with Combivir, your doctor will monitor you closely for any signs that you may be developing lactic acidosis.
As the active ingredients of Combivir may inhibit cellular DNA replication,